Skip to main content
. Author manuscript; available in PMC: 2022 Aug 5.
Published in final edited form as: Liver Transpl. 2015 Jun;21(6):718–737. doi: 10.1002/lt.24122

TABLE 3.

Features of Liver-Directed Non-Viral Gene Therapy Methods

Method Integration and persistence In vivo gene transfer efficiency to liver Liver-specificity Immunological*, integration site and transgene size

NON-VIRAL VECTORS:
Sleeping Beauty Transposons Permanent High efficiency Liver targeted Probably non-immunogenic; preferentially inserts transgenes into TA dinucleotide sites in nontranscribed and intronic regions; ~10kB - efficiency decreases with transgene size
PiggyBac Transposons Permanent High efficiency Liver targeted Probably non-immunogenic; ability to integrate relatively large transgenes (up to 100-kb); TTAA target sequences
PhiC31 Integrase Permanent High efficiency Liver targeted Probably non-immunogenic; unlimited transgene size; integrates in mammalian genome at pseudo attP sites